KEGG   DRUG: Glycopyrrolate and formoterol
Entry
D11036            Mixture   Drug                                   
Name
Glycopyrrolate and formoterol;
Bevespi (TN)
Product
BEVESPI AEROSPHERE (AstraZeneca Pharmaceuticals LP)
Component
Glycopyrrolate [DR:D00540], (Formoterol fumarate [DR:D01373] | Formoterol fumarate hydrate [DR:D05277] | Formoterol [DR:D07990])
Remark
Therapeutic category: 2259
ATC code: R03AL07
Product: D11036<JP/US>
Efficacy
Bronchodilator
  Disease
Chronic obstructive pulmonary disease [DS:H01714]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 R RESPIRATORY SYSTEM
  R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
   R03A ADRENERGICS, INHALANTS
    R03AL Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
     R03AL07 Formoterol and glycopyrronium bromide
      D11036  Glycopyrrolate and formoterol <JP/US>
USP drug classification [BR:br08302]
 Respiratory Tract/Pulmonary Agents
  Bronchodilator Combinations
   Glycopyrrolate/ Formoterol Fumarate
    D11036  Glycopyrrolate and formoterol
Therapeutic category of drugs in Japan [BR:br08301]
 2  Agents affecting individual organs
  22  Respiratory organ agents
   225  Bronchodilators
    2259  Others
     D11036  Glycopyrrolate and formoterol
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D11036
Other DBs
PubChem: 350078355
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system